Navigation Links
Adimarket, Inc. Reaches Agreement with Equipmed to Promote and Distribute DermaPen Throughout Latin America and the Caribbean
Date:10/1/2013

Miami (PRWEB) October 01, 2013

Adimarket, Inc., a leading provider of in-office regenerative medicine solutions, has reached an agreement with Australian cosmetic equipment company Equipmed to promote and distribute the DermaPen aesthetic reintegration tool for collagen and platelet-rich plasma induction throughout Latin America and the Caribbean.

The DermaPen is a state-of-the-art skin-needling roller designed to increase the effectiveness of collagen and elastin rejuvenation treatments, and promote natural collagen reproduction similar to fractional laser treatments, IPL, laser resurfacing and chemical peels, without the side effects. DermaPen is safer and more effective than traditional skin needling rollers because of its vertical needling technology that increases the absorption of products, which are supplied to the skin’s deeper layers.

Treatment times are shorter with DermaPen, and patients experience less pain, less bleeding and less downtime. The DermaPen is used for a variety of treatments including skin tightening, natural collagen induction, lifting & rejuvenation, acne scar and wound healing, minimizing wrinkles and fine lines, pore minimization and alopecia treatments.

The decision to add DermaPen to its product base is part of Adimarket’s commitment to provide re-integration tools to biologics and other stem cell applications. Although DermaPen is already known to be an innovative and versatile tool in the aesthetic and cosmetic arena, Adimarket is also promoting its proven rejuvenating effects in combination with platelet-rich plasma.

For more information, visit the Adimarket website, email info(at)adimarket(dot)net, or call 305-224-1858.

About Adimarket:

Adimarket, Inc., a division of the Global Stem Cells Group, is a cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals.

Adimarket was founded to provide physicians and other health care professionals the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact the practice of stem cell medicine can have when dispensed in a doctor's office, Adimarket provides physicians with the tools they need to provide patients with cutting edge treatments.

Adimarket’s experienced customer service representatives provide valuable guidance and advice regarding products relevant to individual practices.

About the Global Stem Cell Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

The Global Stem Cell Foundation was formed as a non-profit charitable organization that aims to fund research on the expanding need for stem cell solutions for patients, and identify best practices between physicians engaged in stem cell treatments in the U.S. and around the world.

To learn more about Global Stem Cells Group, Inc.’s companies, and for investor information, visit the Global Stem Cell Group website, email bnovas(at)regenestem(dot)com, or call 305-224-1858.

Read the full story at http://www.prweb.com/releases/Adimarket/dermapen/prweb11181898.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. ISN Reaches 50,000 Subscriber Milestone
2. Leading the Site CTMS Market: Clinical Conductor CTMS Reaches 1,600 Sites
3. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of PROLOR Biotech, Inc. in Connection with the Sale of the Company to OPKO Health, Inc.
4. Rosetta Genomics Reaches Settlement Agreement with Sanra Laboratories in Connection with Previous Sale of Parkway Clinical Laboratories
5. Credit Card Processor CPN’s Water Filter Donation Reaches Haiti
6. Shire Reaches Agreement in Principle With U.S. Government
7. Mold from Sandy Remains a Problem in Rockaways; My Cleaning Products Reaches Out to Help with Its Green Mold Removal Spray
8. K-V Pharmaceutical Secures Commitment for $85 Million Loan, Reaches Agreement with Senior Noteholders on Principal Terms of Plan of Reorganization
9. Cold Adds Up to Sandy Victims' Mold Problems; Optimal Chemical Reaches Out to Help by Advising the Use of Molderizer
10. Pressure BioSciences, Inc. Reaches Agreement with Investors on Initial $600,000 Tranche of $1.2 Million Above-Market Private Placement; Proceeds to Support Continued Commercialization of PCT Product Platform
11. Mold Threats Debby Flood Victims, Molderizer Reaches Out With Non-Toxic Mold Remediation Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 27, 2016 , ... Parallel 6 , the leading software as a ... Reach Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine ... team. , Using the CONSULT module, patients and physicians can schedule a face to ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
Breaking Biology Technology:
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
Breaking Biology News(10 mins):